Kyverna Therapeutics, Inc. (KYTX)

NMS – Real vaqt narxi. Valyuta: USD

8.09

+0.07 (0.87%)

Bozor ochiq: Aug 12, 2026, 3:25 PM EDT

8.02

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

11.08.2026

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

FDA grants RMAT designation for miv-cel in non-active secondary progressive multiple sclerosis (naSPMS) based on compelling clinical data, further expanding the therapy's potential across neuroimmunology

Videolar

No Data

There is no data to display

Press-relizlar

11.08.2026

Kyverna Therapeutics, Inc. (KYTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Search stocks

Kyverna Therapeutics, Inc. (KYTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results